Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?

about

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?

Item

http://www.wikidata.org/entity/Q35727675

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Individualized initiation of s ...... likely to achieve goal LDL-C?

@ast

Individualized initiation of s ...... likely to achieve goal LDL-C?

@en

type

Item

label

Individualized initiation of s ...... likely to achieve goal LDL-C?

@ast

Individualized initiation of s ...... likely to achieve goal LDL-C?

@en

prefLabel

Individualized initiation of s ...... likely to achieve goal LDL-C?

@ast

Individualized initiation of s ...... likely to achieve goal LDL-C?

@en

P1476

Individualized initiation of s ...... likely to achieve goal LDL-C?

@en

P2093

Debra K Farver

http://www.w3.org/2001/XMLSchema#string

James R Clem

http://www.w3.org/2001/XMLSchema#string

Joe D Strain

http://www.w3.org/2001/XMLSchema#string

P2860

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Flexible initial dosing of atorvastatin based upon initial low-density lipoprotein cholesterol levels in type 2 diabetic patients

Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia.

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/RMHP.S7376

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22312212

http://www.w3.org/2001/XMLSchema#string

P921

statin therapy

P932

3270916

http://www.w3.org/2001/XMLSchema#string